Healthcare providers in Kentucky have been selected for a major global Phase 3 COVID-19 vaccine clinical trial, including University of Kentucky (UK) Hospital, Baptist Health Lexington and Norton Healthcare in Louisville serve as trial site locations for the massive...
University of Kentucky
Category
University of Kentucky Embraces Ivermectin & Other Experimental Medications in ‘Pick-the-Winner’ COVID-19 Trial
Clinical leaders from the University of Kentucky Markey Cancer Center College of Medicine and College of Pharmacy are now embarking on a novel path to investigate COVID-19 therapies. In a first in the United States, a major academic medical center has taken on...
Rep. Moser’s Vision for University of Kentucky as Center for Cannabis Research Including Clinical Trials
Kentucky lawmakers seek to establish a $4 million Kentucky Center for Cannabis Research at the University of Kentucky in pursuit of advancing the study of cannabis use for medical treatment. The proposed center would support UK’s move to become the preeminent cannabis...
UK Markey Cancer Center Patient sees Disease go into Remission Thanks to Experimental Drug
A Kentucky woman named Jenn Highfeld was facing the end of life. With a family history of colon cancer, she was diagnosed with the terrible disease at 38. After second opinions and multiple consultations, she was treated at University of Kentucky (UK) Markey Cancer...
University of Kentucky: A Hub of Clinical Research in the Appalachian Region of America
Few understand the importance of clinical trials and their contribution to advancements in medicine. Even fewer understand the challenge in finding patients for studies. The University of Kentucky recently touted not only research but its commitment to advancing...
University of Kentucky Receives $87 Million to Combat Opioid Crisis
University of Kentucky received $87 Million from the U.S. federal government to target the opioid epidemic in that state, as was reported in WFPL. The money will be spent over the next four years with the targeted goal of opioid overdose reduction through...
Ann Morris Univ. of KY Receives $1.9 Million to Study Retinal Regeneration
Jenny Wells, an associate professor in the University of Kentucky College of Arts and sciences has received $1.87 million from the National Institutes of Health (NIH) to continue her innovative research in retinal development and regeneration. Lead...